Guangdong Provincial Hospital of Traditional Chinese Medicine   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Guangzhou China (1933)

Organization Overview

First Clinical Trial
2007
NCT00547950
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Guangdong Province Hospital of Tradtional Chinese Medicine | Guangdong Provincial Hospital of Traditional Chinese Medicine | Guangdong Provincial Hospital of Tradtional Chinese Medicine | shuai Mao | Yanjuan Zhu

Active Ingredients

Drugs in Phase 4 Trials (19)

acetylsalicylic acid (aspirin) (2 trials)

danlou (1 trial)

danshen-201 (1 trial)

deng zhan sheng mai (2 trials)

desirudin (Ipravask) (1 trial)

erigeron (1 trial)

fufangshuanghua (1 trial)

insulin human (humulin) (1 trial)

jinyebaidu (1 trial)

levofloxacin (levaquin) (1 trial)

linagliptin (tradjenta) (1 trial)

lithium (lithonate) (1 trial)

qingpeng (1 trial)

salvianolate (1 trial)

sitagliptin (januvia) (1 trial)

sugammadex (bridion) (1 trial)

tabanus (1 trial)

tongguan (1 trial)

xingnaojing (1 trial)

Drugs in Phase 3 Trials (7)

capecitabine (xeloda) (2 trials)

fulvestrant (faslodex) (1 trial)

gimeracil (1 trial)

oteracil (1 trial)

s-1 (1 trial)

sanfujiu (1 trial)

tegafur (1 trial)

Drugs in Phase 2 Trials (29)

abiraterone (zytiga) (1 trial)

allogeneic central memory t cells (1 trial)

anlotinib (2 trials)

apatinib (1 trial)

astragalus radix (2 trials)

autologous adipose-derived mesenchymal stem cells (4 trials)

bicalutamide (casodex) (1 trial)

c-117 (1 trial)

c-177 (1 trial)

calcipotriene (dovonex) (2 trials)

camrelizumab (1 trial)

cytokine induced killer cells (1 trial)

folic acid (1 trial)

fuzheng yiliu (1 trial)

goserelin (zoladex) (1 trial)

gu ben hua yu fang (2 trials)

herba cistanches (1 trial)

herba epimedii (1 trial)

moluodan (1 trial)

oxaliplatin (eloxatin) (2 trials)

poria (1 trial)

psori-cm01 (3 trials)

radix codonopsitis (1 trial)

radix morindae officinalis (1 trial)

rhizoma atractylodis macrocephalae (1 trial)

rhizoma dioscoreae (1 trial)

sanchi-tongshu (1 trial)

semen cuscutae (1 trial)

umbilical cord mesenchymal stem cells (1 trial)

Drugs in Phase 1 Trials (2)

famotidine (pepcid) (1 trial)

secukinumab (cosentyx) (1 trial)

Drugs in Other Trials (21)

altacite (1 trial)

azimtamide (1 trial)

docetaxel (taxotere) (1 trial)

escitalopram (lexapro) (1 trial)

fluorouracil (efudex) (2 trials)

fuganlin (1 trial)

ginseng (1 trial)

irinotecan (Camptosar) (2 trials)

leucovorin (2 trials)

pinellia (1 trial)

radix curcumae (1 trial)

radix scutellariae (1 trial)

raloxifene (evista) (1 trial)

rhizoma atractylodis (1 trial)

rhizoma coptidis (1 trial)

rhizoma zingiberis (1 trial)

roasted bighead atractylodes rhizome (1 trial)

si-ni-tang (1 trial)

spreading hedyotis herb (1 trial)

tislelizumab (1 trial)

xiaochaihu-tang (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Angina Pectoris (Phase 4)

Breast Neoplasms (Phase 3)

Carcinoma (Phase 3)

Carotid Stenosis (Phase 2)

Cerebral Hemorrhage (Phase 4)

Cerebral Infarction (Phase 4)

Colonic Neoplasms (Phase 2)

Colorectal Neoplasms (Phase 3)

Communicable Diseases (Phase 4)

Coronary Artery Disease (Phase 4)

Coronary Disease (Phase 4)

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 2 (Phase 4)

Drug-Related Side Effects and Adverse Reactions (Phase 2)

Gastroesophageal Reflux (Phase 1)

Heart Diseases (Phase 4)

Hemorrhage (Phase 4)

Hypertriglyceridemia (Phase 4)

Infarction (Phase 4)

Infections (Phase 4)

Intracranial Arteriosclerosis (Phase 2)

Intracranial Embolism (Phase 2)

Intracranial Thrombosis (Phase 2)

Ischemia (Phase 4)

Kidney Diseases (Phase 2)

Kidney Failure, Chronic (Phase 2)

Myocardial Infarction (Phase 4)

Myocardial Ischemia (Phase 4)

Osteosarcoma (Phase 4)

Pancreatitis (Phase 4)

Peritoneal Neoplasms (Phase 3)

Precancerous Conditions (Phase 2)

Prostatic Neoplasms (Phase 2)

Psoriasis (Phase 2)

Respiratory Tract Infections (Phase 4)

Rhinitis (Phase 3)

Rhinitis, Allergic (Phase 3)

Stomach Neoplasms (Phase 3)

Stroke (Phase 4)

Urinary Tract Infections (Phase 4)

Ventricular Remodeling (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 45
  • # of Trial APIs: 78